Longboard Asset Management LP Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Longboard Asset Management LP acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 480 shares of the medical equipment provider’s stock, valued at approximately $251,000. Intuitive Surgical comprises about 0.7% of Longboard Asset Management LP’s holdings, making the stock its 20th biggest holding.

Several other large investors have also recently modified their holdings of ISRG. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical during the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $82,517,000. Exome Asset Management LLC boosted its stake in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Consolidated Planning Corp grew its holdings in shares of Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of Intuitive Surgical by 73.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock worth $132,657,000 after buying an additional 114,149 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. Mizuho raised their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Raymond James boosted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 28,843 shares of company stock worth $15,357,560. 0.80% of the stock is owned by insiders.

Intuitive Surgical Stock Up 1.2 %

Shares of ISRG opened at $578.55 on Tuesday. The stock has a market cap of $206.07 billion, a P/E ratio of 90.26, a P/E/G ratio of 5.51 and a beta of 1.39. The business’s 50 day moving average price is $550.40 and its 200-day moving average price is $510.02. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.